{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:35:40Z","timestamp":1759826140472},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,7,1]]},"DOI":"10.1373\/clinchem.2005.048751","type":"journal-article","created":{"date-parts":[[2005,6,23]],"date-time":"2005-06-23T21:23:28Z","timestamp":1119561808000},"page":"1276-1279","source":"Crossref","is-referenced-by-count":17,"title":["Invasive Trophoblast Antigen (Hyperglycosylated Human Chorionic Gonadotropin) as a First-Trimester Serum Marker for Down Syndrome"],"prefix":"10.1093","volume":"51","author":[{"given":"Martin JN","family":"Weinans","sequence":"first","affiliation":[{"name":"Antenatal Diagnosis Unit, Department of Obstetrics and Gynaecology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Sancken","sequence":"first","affiliation":[{"name":"Institut fu\u0308r Humangenetik der Universita\u0308t Go\u0308ttingen, Go\u0308ttingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj","family":"Pandian","sequence":"first","affiliation":[{"name":"Quest Diagnostics Nichols Institute, San Juan Capistrano, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jody MW","family":"van de Ouweland","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University Hospital, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henk WA","family":"de Bruijn","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University Hospital, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozien P","family":"Holm","sequence":"first","affiliation":[{"name":"Antenatal Diagnosis Unit, Department of Obstetrics and Gynaecology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Mantingh","sequence":"first","affiliation":[{"name":"Antenatal Diagnosis Unit, Department of Obstetrics and Gynaecology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,7,1]]},"reference":[{"key":"2020022800522014800_R1","doi-asserted-by":"crossref","unstructured":"Elliott MM, Kardana A, Lustbader JW, Cole LA. Carbohydrate and peptide structure of the \u03b1- and \u03b2-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma. Endocrine1997;7:15-32.","DOI":"10.1007\/BF02778058"},{"key":"2020022800522014800_R2","doi-asserted-by":"crossref","unstructured":"Kovalevskaya G, Genbacev O, Fisher SJ, Caceres E, O\u2019Connor JF. Trophoblast origin of hCG isoforms: cytotrophoblasts are the primary source of choriocarcinoma-like hCG. Mol Cell Endocrinol2002;194:147-155.","DOI":"10.1016\/S0303-7207(02)00135-1"},{"key":"2020022800522014800_R3","doi-asserted-by":"crossref","unstructured":"Cole LA, Khanlian SA, Sutton JM, Davies S, Stephens ND. Hyperglycosylated hCG (invasive trophoblast antigen, ITA) a key antigen for early pregnancy detection. Clin Biochem2003;36:647-655.","DOI":"10.1016\/S0009-9120(03)00108-5"},{"key":"2020022800522014800_R4","doi-asserted-by":"crossref","unstructured":"Kovalevskaya G, Birken S, Kakuma T, Ozaki N, Sauer M, Lindheim S, et al. Differential expression of human chorionic gonadotropin (hCG) glycosylation isoforms in failing and continuing pregnancies: preliminary characterization of hyperglycosylated hCG epitope. J Endocrinol2002;172:497-506.","DOI":"10.1677\/joe.0.1720497"},{"key":"2020022800522014800_R5","doi-asserted-by":"crossref","unstructured":"Frendo JL, Vidaud M, Guibourdenche J, Luton D, Muller F, Bellet D, et al. Defect of villous cytotrophoblast differentiation into syncytiotrophoblast in Down\u2019s syndrome. J Clin Endocrinol Metab2000;85:3700-3707.","DOI":"10.1210\/jcem.85.10.6915"},{"key":"2020022800522014800_R6","doi-asserted-by":"crossref","unstructured":"Cole LA, Shahabi S, Oz UA, Bahado-Singh RO, Mahoney MJ. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: a new basis for gestational Down syndrome screening. Clin Chem1999;45:2109-2119.","DOI":"10.1093\/clinchem\/45.12.2109"},{"key":"2020022800522014800_R7","doi-asserted-by":"crossref","unstructured":"Cole LA, Shahabi S, Oz UA, Rinne KM, Omrani A, Bahado-Singh RO, et al. Urinary screening tests for fetal Down syndrome: II. Hyperglycosylated hCG. Prenat Diagn1999;19:351-359.","DOI":"10.1002\/(SICI)1097-0223(199904)19:4<351::AID-PD546>3.0.CO;2-X"},{"key":"2020022800522014800_R8","doi-asserted-by":"crossref","unstructured":"Palomaki GE, Knight GJ, Roberson MM, Cunningham GC, Lee JC, Strom CM, et al. Invasive trophoblast antigen (hyperglycosylated human chorionic gonadotropin) in second-trimester maternal urine as a marker for Down syndrome: preliminary results of an observational study on fresh samples. Clin Chem2004;50:182-189.","DOI":"10.1373\/clinchem.2003.023986"},{"key":"2020022800522014800_R9","doi-asserted-by":"crossref","unstructured":"Weinans MJN, Butler SA, Mantingh A, Cole LA. Urinary hyperglycosylated hCG in first trimester screening for chromosomal abnormalities. Prenat Diagn2000;20:976-978.","DOI":"10.1002\/1097-0223(200012)20:12<976::AID-PD962>3.0.CO;2-2"},{"key":"2020022800522014800_R10","doi-asserted-by":"crossref","unstructured":"Shahabi S, Oz UA, Bahado-Singh RO, Mahoney MJ, Omrani A, Baumgarten A, et al. Serum hyperglycosylated hCG: a potential screening test for fetal Down syndrome. Prenat Diagn1999;19:488-489.","DOI":"10.1002\/(SICI)1097-0223(199905)19:5<488::AID-PD545>3.0.CO;2-F"},{"key":"2020022800522014800_R11","doi-asserted-by":"crossref","unstructured":"Pandian R, Lu J, Ossolinska-Plewnia J. Fully automated chemiluminometric assay for hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen). Clin Chem2003;49:808-810.","DOI":"10.1373\/49.5.808"},{"key":"2020022800522014800_R12","unstructured":". Central Bureau of Statistics. Voorburg\/Heerlen2004 CBS The Netherlands. ."},{"key":"2020022800522014800_R13","doi-asserted-by":"crossref","unstructured":"Cole LA, Omrani A, Cermik D, Bahado-Singh RO, Mahoney MJ. Hyperglycosylated hCG, a potential alternative to hCG in Down syndrome screening. Prenat Diagn1998;18:926-933.","DOI":"10.1002\/(SICI)1097-0223(199809)18:9<926::AID-PD377>3.0.CO;2-F"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/51\/7\/1276\/32683495\/clinchem1276.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/51\/7\/1276\/32683495\/clinchem1276.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T05:52:34Z","timestamp":1582869154000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/51\/7\/1276\/5630016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,1]]},"references-count":13,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2005,7,1]]},"published-print":{"date-parts":[[2005,7,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2005.048751","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2005,7,1]]},"published":{"date-parts":[[2005,7,1]]}}}